Abstract:Data on both the incidence of slow acetylator phenotype of probe drugs isoniazid, sulfadimidine or sulfamethazine, caffeine and dapsone in mainland or overseas Chinese, and the distribution of NAT2 genotypes and the frequency of NAT2 alleles in the Chinese populations were summarized and reanalysed using a meta-analysis method. Frequency of the slow acetylator phenotype in 3516 healthy Han Chinese gave an overall mean of approximately 19.9 +/- 4.0%, with the range of the combined data being between 15.8% and 25.5%. In addition, frequencies of the slow acetylator phenotype differ between the different minorities in Chinese populations and the range was between 3.2% and 50.6%, with a mean value of 20.6 +/- 12.9% in a total of 1842 individuals from 17 Chinese minorities. In addition, there was no significant heterogeneity in overseas Chinese between the probe drugs isoniazid and sulfadimidine or sulfamethazine (chi 2 = 5.97, df = 4; p > 0.05), and the mean value of slow acetylator phenotype incidence was 24.5% (119/485; 95% CI: 20.7-28.3%), consistent with that of the native Chinese. As expected, frequency of the slow acetylator genotypes in Chinese populations was 25.4% (112/441; 95% CI: 21.3-29.5%), which was in accordance with that of the slow acetylator phenotype in native or overseas Chinese. For all genotypes, *4/*4 (29.9%, 132/441), *4/*6A (27.4%, 121/441), *4/*7A (12%, 53/441) and *6A/*6A (11.3%, 50/441) occupied 80.6%, but *5A/*7A (0.2%, 1/441), *5A/*5A (1.1%, 5/441) and *7A/*7A (1.8%, 8/441) were not frequently found. From this report, the genotype frequencies of homozygous rapid acetylator, heterozygous rapid acetylator, and homozygous slow acetylator were found to be 0.299 (132/441), 0.447 (197/441) and 0.254 (112/441), respectively. Furthermore, both *4 (52.3%; 95% CI: 49-56%) and *6A (30.5%; 95% CI: 28-34%) were major NAT2 alleles, while *7A (11.2%; 95% CI: 9-13%) and *5A (6%; 95% CI: 4-8%) were uncommonly present. Frequency of the mutant alleles was observed at 0.477 (421/882 alleles). The *7A constituted 23.5% t(99/421) of slow acetylator alleles in Chinese populations, showing that this point mutation exists not only in Oriental or Asiatic, but also in Chinese populations. According to the Hardy-Weinberg equilibrium, in the phenotyped Chinese populations, the mean estimate of predicted allelic frequencies of the genotypes RR, Rr, and rr was 0.294, 0.496, and 0.210 for the Chinese, and the expected frequency of the deficient gene r was 0.458. By comparison, the predicted values are in complete agreement with the observed ones. In conclusion, this meta-analysis determined the accurate population frequencies of phenotype and genotype of the NAT2 genetic deficiency in healthy Chinese subjects.

Genetic-Analysis Of The S-Mephenytoin Polymorphism In A Chinese Population

THE PHENOTYPE AND GENOTYPE ANALYSIS OF S-MEPHENYTOIN HYDROXYLASE (CYP2C19) IN CHINESE SUBJECTS

Genetic Variations of S-mephenytoin 4'-Hydroxylase (CYP2C19) in the Chinese Population.

Allelic, Genotypic and Phenotypic Distributions of S-mephenytoin 4'-Hydroxylase (CYP2C19) in Healthy Caucasian Populations of European Descent Throughout the World.

Genetic Polymorphisms of Debrisoquine and S-mephenytoin Oxidation Metabolism in Chinese Populations: a Meta-Analysis.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Genetic Polymorphism of (S)-Mephenytoin 4'-Hydroxylation in Populations of African Descent.

Phenotype analysis of cytochrome P450 2C19 in Chinese subjects with mephenytoin S/R enantiomeric ratio in urine measured by chiral GC

Phenotype analysis of cytochrome P4502C19 in Chinese subjects with mephenytoin S/R enantiomeric ratio in urine measured by chiral GC

Phenotype analysis of cytochrome P450 2C19 in Chinese subjects with mephenytoinS/R enantiomeric ratio in urine measured by chiral GC

[Polymorphisms of Drug-Metabolizing Enzymes Genes in a Han Chinese Population].

Evidence for the effect of gender on activity of (S)-mephenytoin 4'-hydroxylase (CYP2C19) in a Chinese population.

Study on Cytochrome P-450 2C19 Genetic Polymorphism in Zhejiang Han and She Nationalities

Differences in Genotype and Allele Frequency Distributions of Polymorphic Drug Metabolizing Enzymes CYP2C19 and CYP2D6 in Mainland Chinese Mongolian, Hui and Han Populations

Meta-analysis of Phenotype and Genotype of NAT2 Deficiency in Chinese Populations.

Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients

A New Tumor-Related Gene-CYP2C19

Correlation of Genetic Polymorphism of Cytochrome P4502D6 with Dextromethorphan Oxidative Metabolism in Chinese.

Frequency of CYP2D610 and 14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

The G-113a Polymorphism In Cyp1a2 Affects The Caffeine Metabolic Ratio In A Chinese Population

[The Polymorphism of Cytochrome P(450) 2C19 Gene in Patients with Invasive Fungal Infections.].